VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol
NCT07286461
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
290
Enrollment
OTHER
Sponsor class
Conditions
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
CMV
Interventions
DRUG:
letermovir prophylaxis
Sponsor
University of Rome Tor Vergata
Collaborators
[object Object]